Institute for Systems Biology
3
10M
2
0.14
0.33
- Areas of investment
Summary
In 2000 was created Institute for Systems Biology, which is appeared as Corporate Investor. The fund was located in North America if to be more exact in United States. The main department of described Corporate Investor is located in the Seattle.
Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular portfolio startups of the fund, we may highlight Theraclone Sciences. Among the most successful fund investment fields, there are Medical, Biotechnology.
The top activity for fund was in 2006. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is generally included in less than 2 deals every year.
The typical case for the fund is to invest in rounds with 5 participants. Despite the Institute for Systems Biology, startups are often financed by Versant Ventures, MPM Capital, Alexandria Real Estate Equities. The meaningful sponsors for the fund in investment in the same round are ARCH Venture Partners, Versant Ventures, MPM Capital. In the next rounds fund is usually obtained by Amgen Ventures, Alexandria Real Estate Equities, ARCH Venture Partners.
This organization was formed by Leroy Hood.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 0
- Rounds per year
- 0.14
- Follow on index
- 0.33
- Investments by industry
- Venture Capital (2)
- Finance (2)
- Banking (2)
- Biotechnology (1)
- Health Care (1) Show 4 more
- Investments by region
-
- United States (3)
- Peak activity year
- 2003
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 18
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Theraclone Sciences | 03 Mar 2006 | Decision/Risk Analysis, Biotechnology, Drug Delivery, Health Care, Medical, Therapeutics | Early Stage Venture | 4M | United States, Washington, Seattle |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.